EFE Agency

Lima, January 13, 2022Updated on 01/13/2022 07:08 pm

Colombia reported this Thursday of 96 deaths from COVID-19, a figure that had not been registered since mid-August, while cases rose again and 30,283 were reported, according to data provided by the Ministry of Health.

LOOK: The criminal history of the kidnapper of the Colombian Lina Cruz in Mexico

With these data, Colombia accumulates 130,625 deaths from coronavirus and 5,440,981 infections, of which 167,617 cases remain active.

The positivity rate, of the 109,502 tests processed today (46,623 PCR and 62,879 antigens), is 27.6%.

The increase in cases and deaths is attributed by the authorities to the omicron variant, which is already dominant in the country.

The Ministry of Health said today that of the 10,917 existing intensive care unit (ICU) beds, 42.37% are available, and of those occupied only 23% are from suspected or confirmed COVID-19 patients.

According to the Ministry of Health, the regions that had the highest infections this Thursday were Bogotá (7,208), Antioquia (4,615), Valle del Cauca (3,962), Bolívar (2,229) and Atlántico (2,222).

According to health authorities, 289,442 vaccines against the coronavirus were applied last Tuesday, of which 125,198 were second doses and 16,591 are of the single-dose formula of the pharmaceutical company Janssen.

With these figures, in Colombia 66,935,960 vaccines have been applied and 29.4 million people already have their complete schedule (58.8% of the population), while 4,030,813 have received the booster dose.

According to the criteria of

Trust Project

Know more

RECOMMENDED VIDEO

This is the protests for health restrictions of COVID-19 in the world
Protests for restrictions and escalation of COVID-19 cases in the world Demonstrations against sanitary restrictions due to the covid-19 pandemic were registered on Sunday in Belgium and Denmark, amid an increase in infections related to the omicron variant, which puts pressure also on the UK and Israel. (Source: AFP)

IT MAY INTEREST YOU

Leave a Reply